Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistance.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

remdesivir - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/41581457

Alexander Mellmann; Andre Schreiber; Benjamin Ambrosy; Darisuren Anhlan; Stefan Bletz; Stephan Ludwig

Jan 26, 2026